Silencing of Wnt5a during colon cancer metastasis involves histone modifications

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277 - 300; http://dx.doi.org/10.3322/caac.20073; PMID: 20610543
   PubMed Web of Science ®Google Scholar
• Segal NH, Saltz LB. Evolving treatment of advanced colon cancer. Annu Rev Med 2009; 60:207 - 19; http://dx.doi.org/10.1146/annurev.med.60.041807.132435; PMID: 19630571
   PubMed Web of Science ®Google Scholar
• Sheldahl LC, Park M, Malbon CC, Moon RT. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 1999; 9:695 - 8; http://dx.doi.org/10.1016/S0960-9822(99)80310-8; PMID: 10395542
   PubMed Web of Science ®Google Scholar
• Slusarski DC, Yang-Snyder J, Busa WB, Moon RT. Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A. Dev Biol 1997; 182:114 - 20; http://dx.doi.org/10.1006/dbio.1996.8463; PMID: 9073455
   PubMed Web of Science ®Google Scholar
• Umbhauer M, Djiane A, Goisset C, Penzo-Méndez A, Riou JF, Boucaut JC, et al. The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling. EMBO J 2000; 19:4944 - 54; http://dx.doi.org/10.1093/emboj/19.18.4944; PMID: 10990458
   PubMed Web of Science ®Google Scholar
• He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 1997; 275:1652 - 4; http://dx.doi.org/10.1126/science.275.5306.1652; PMID: 9054360
   PubMed Web of Science ®Google Scholar
• Olson DJ, Gibo DM. Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. Exp Cell Res 1998; 241:134 - 41; http://dx.doi.org/10.1006/excr.1998.4030; PMID: 9633521
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010; 29:2036 - 46; http://dx.doi.org/10.1038/onc.2009.496; PMID: 20101234
   PubMed Web of Science ®Google Scholar
• Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q, Potter L, et al. WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 2008; 14:5825 - 32; http://dx.doi.org/10.1158/1078-0432.CCR-07-5104; PMID: 18794093
   PubMed Web of Science ®Google Scholar
• Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, et al. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 2008; 14:55 - 61; http://dx.doi.org/10.1158/1078-0432.CCR-07-1644; PMID: 18172252
   PubMed Web of Science ®Google Scholar
• Kremenevskaja N, von Wasielewski R, Rao AS, Schöfl C, Andersson T, Brabant G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 2005; 24:2144 - 54; http://dx.doi.org/10.1038/sj.onc.1208370; PMID: 15735754
   PubMed Web of Science ®Google Scholar
• Medrek C, Landberg G, Andersson T, Leandersson K. Wnt-5a-CKIalpha signaling promotes beta-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem 2009; 284:10968 - 79; http://dx.doi.org/10.1074/jbc.M804923200; PMID: 19244247
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Jimenez-Velasco A, Cordeu L, Vilas-Zornoza A, San Jose-Eneriz E, Garate L, et al. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. Eur J Cancer 2007; 43:2736 - 46; http://dx.doi.org/10.1016/j.ejca.2007.10.004; PMID: 18032022
   PubMed Web of Science ®Google Scholar
• Dejmek J, Dejmek A, Säfholm A, Sjölander A, Andersson T. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 2005; 65:9142 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-05-1710; PMID: 16230369
   PubMed Web of Science ®Google Scholar
• Witze ES, Litman ES, Argast GM, Moon RT, Ahn NG. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science 2008; 320:365 - 9; http://dx.doi.org/10.1126/science.1151250; PMID: 18420933
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Fumoto K, Okamoto T, Kaibuchi K, Kikuchi A. Binding of APC and dishevelled mediates Wnt5a-regulated focal adhesion dynamics in migrating cells. EMBO J 2010; 29:1192 - 204; http://dx.doi.org/10.1038/emboj.2010.26; PMID: 20224554
   PubMed Web of Science ®Google Scholar
• Jensen TJ, Wozniak RJ, Eblin KE, Wnek SM, Gandolfi AJ, Futscher BW. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol 2009; 235:39 - 46; http://dx.doi.org/10.1016/j.taap.2008.10.013; PMID: 19061910
   PubMed Web of Science ®Google Scholar
• Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976; 36:4562 - 9; PMID: 1000501
   PubMed Web of Science ®Google Scholar
• Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos MJ, et al. Validation of a model of colon cancer progression. J Pathol 2000; 192:446 - 54; http://dx.doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K; PMID: 11113861
   PubMed Web of Science ®Google Scholar
• Hewitt RE, Brown KE, Corcoran M, Stetler-Stevenson WG. Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line. J Pathol 2000; 192:455 - 9; http://dx.doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH777>3.0.CO;2-E; PMID: 11113862
   PubMed Web of Science ®Google Scholar
• Li Q, Chen H. Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620. Clin Exp Metastasis 2011; 28:127 - 35; http://dx.doi.org/10.1007/s10585-010-9366-4; PMID: 21184144
   PubMed Web of Science ®Google Scholar
• Rodenhiser DI. Epigenetic contributions to cancer metastasis. Clin Exp Metastasis 2009; 26:5 - 18; http://dx.doi.org/10.1007/s10585-008-9166-2; PMID: 18386135
   PubMed Web of Science ®Google Scholar
• Chik F, Szyf M, Rabbani SA. Role of epigenetics in cancer initiation and progression. Adv Exp Med Biol 2011; 720:91 - 104; http://dx.doi.org/10.1007/978-1-4614-0254-1_8; PMID: 21901621
   PubMed Web of Science ®Google Scholar
• Li Q, Chen H. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis. Epigenetics 2011; 6:849 - 52; http://dx.doi.org/10.4161/epi.6.7.16314; PMID: 21758003
   PubMed Web of Science ®Google Scholar
• von Burstin J, Eser S, Paul MC, Seidler B, Brandl M, Messer M, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 2009; 137:361 - 71, 371, e1-5; http://dx.doi.org/10.1053/j.gastro.2009.04.004; PMID: 19362090
   PubMed Web of Science ®Google Scholar
• Su HY, Lai HC, Lin YW, Liu CY, Chen CK, Chou YC, et al. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 2010; 127:555 - 67; http://dx.doi.org/10.1002/ijc.25083; PMID: 19957335
   PubMed Web of Science ®Google Scholar
• Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, et al. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer 2011; 128:541 - 50; http://dx.doi.org/10.1002/ijc.25357; PMID: 20340127
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823 - 37; http://dx.doi.org/10.1016/j.cell.2007.05.009; PMID: 17512414
   PubMed Web of Science ®Google Scholar
• Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441:349 - 53; http://dx.doi.org/10.1038/nature04733; PMID: 16625203
   PubMed Web of Science ®Google Scholar
• Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40:741 - 50; http://dx.doi.org/10.1038/ng.159; PMID: 18488029
   PubMed Web of Science ®Google Scholar
• Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232 - 6; http://dx.doi.org/10.1038/ng1950; PMID: 17200670
   PubMed Web of Science ®Google Scholar
• Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410:120 - 4; http://dx.doi.org/10.1038/35065138; PMID: 11242054
   PubMed Web of Science ®Google Scholar
• Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for?. J Cell Sci 2003; 116:3677 - 85; http://dx.doi.org/10.1242/jcs.00735; PMID: 12917355
   PubMed Web of Science ®Google Scholar
• Nowak SJ, Corces VG. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 2004; 20:214 - 20; http://dx.doi.org/10.1016/j.tig.2004.02.007; PMID: 15041176
   PubMed Web of Science ®Google Scholar
• Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 2011; 3:166 - 79; PMID: 21416059
   PubMed Web of Science ®Google Scholar
• Mossman D, Scott RJ. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. PLoS One 2011; 6:e23127; http://dx.doi.org/10.1371/journal.pone.0023127; PMID: 21829702
   PubMedGoogle Scholar
• Kikuchi A, Yamamoto H, Sato A, Matsumoto S. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol (Oxf) 2012; 204:17 - 33; http://dx.doi.org/10.1111/j.1748-1716.2011.02294.x; PMID: 21518267
   PubMed Web of Science ®Google Scholar
• Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, et al. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol Ther 2010; 10:617 - 24; http://dx.doi.org/10.4161/cbt.10.6.12609; PMID: 20603606
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen H. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res 2010; 30:4537 - 45; PMID: 21115903
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Jimenez-Velasco A, Cordeu L, Vilas-Zornoza A, San Jose-Eneriz E, Garate L, et al. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. Eur J Cancer 2007; 43:2736 - 46; http://dx.doi.org/10.1016/j.ejca.2007.10.004; PMID: 18032022
   PubMed Web of Science ®Google Scholar
• Chen H, Pan YX, Dudenhausen EE, Kilberg MS. Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. J Biol Chem 2004; 279:50829 - 39; http://dx.doi.org/10.1074/jbc.M409173200; PMID: 15385533
   PubMed Web of Science ®Google Scholar